-
Company Profile
![]()
Cepheid Inc – Company Profile
Cepheid Inc (Cepheid), a subsidiary of Danaher Corp, is a molecular diagnostic company that develops, manufactures, and markets molecular systems and conducts tests for clinical and non-clinical markets. The company offers in vitro diagnostic tests for health care associated infections, critical infectious diseases, sexual health, virology, oncology and genetics, molecular diagnostic systems, and reagents and parts. Cepheid distributes its products directly and through a network of distributors present across the Americas, Asia, Europe, Africa and the Middle East. The company...
Add to Basket -
Product Insights
Respiratory Disease Tests – Cepheid Inc – XPERT
GlobalData, the industry analysis specialist, has released its latest report: Respiratory Disease Tests - Cepheid Inc - XPERT. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by the...
-
Product Insights
Multiplex Infectious Disease Tests – Cepheid Inc – XPERT
GlobalData, the industry analysis specialist, has released its latest report: Multiplex Infectious Disease Tests - Cepheid Inc - XPERT. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by...
-
Product Insights
Respiratory Disease Tests – Cepheid Inc – XPERT XPRESS
GlobalData, the industry analysis specialist, has released its latest report: Respiratory Disease Tests - Cepheid Inc - XPERT XPRESS. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by...
-
Product Insights
COVID-19 Tests – Cepheid Inc – XPERT XPRESS
GlobalData, the industry analysis specialist, has released its latest report: COVID-19 Tests - Cepheid Inc - XPERT XPRESS. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by the...
-
Product Insights
Cepheid Inc Pipeline Insight and Competitive Landscape, 2023
Cepheid Inc (Cepheid), a subsidiary of Danaher Corp, is a molecular diagnostic company that develops, manufactures, and markets molecular systems and conducts tests for clinical and non-clinical markets. The company offers in vitro diagnostic tests for health care associated infections, critical infectious diseases, sexual health, virology, oncology and genetics; molecular diagnostic systems; and reagents and parts. Cepheid distributes its products directly and through a network of distributors present across the Americas, Asia, Europe, Africa and the Middle East. The company...
-
Product Insights
Multiplex Infectious Disease Tests – Cepheid Inc – XPERT EV
GlobalData, the industry analysis specialist, has released its latest report: Multiplex Infectious Disease Tests - Cepheid Inc - XPERT EV. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted...
-
Product Insights
Multiplex Infectious Disease Tests – Cepheid Inc – XPERT XPRESS
GlobalData, the industry analysis specialist, has released its latest report: Multiplex Infectious Disease Tests - Cepheid Inc - XPERT XPRESS. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted...
-
Product Insights
Respiratory Disease Tests – Cepheid Inc – XPERT XPRESS PLUS
GlobalData, the industry analysis specialist, has released its latest report: Respiratory Disease Tests - Cepheid Inc - XPERT XPRESS PLUS. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted...
-
Product Insights
COVID-19 Tests – Cepheid Inc – XPERT XPRESS PLUS
GlobalData, the industry analysis specialist, has released its latest report: COVID-19 Tests - Cepheid Inc - XPERT XPRESS PLUS. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by...
-
Product Insights
Multiplex Infectious Disease Tests – Cepheid Inc – XPERT XPRESS PLUS
GlobalData, the industry analysis specialist, has released its latest report: Multiplex Infectious Disease Tests - Cepheid Inc - XPERT XPRESS PLUS. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also...
-
Sector Analysis
Multi Parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs Market Size by Segments, Share, Regulatory and Reimbursement, Procedures and Forecast to 2033
Multi Parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs Market Report Overview The Multi-Parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) NAATs market size was valued at $1.06 billion in 2022. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic pregnancy, and chronic pelvic pain. Multi-Parameter CT/NG NAATs Market Outlook 2022-2033 ($ Billion) For more insights on the Multi-Parameter CT/NG...
-
Product Insights
Poland PCR Systems Market Share
PCR Systems (In Vitro Diagnostics) Poland Market Share report provides quantitative market trends within the In Vitro Diagnostics therapeutic area. Robust methodologies ensure an accurate overview of the market to deliver a comprehensive and precise market analysis. It incorporates primary sources from both the demand and supply sides. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Product Insights
India PCR Systems Market Share
PCR Systems (In Vitro Diagnostics) India Market Share report provides quantitative market trends within the In Vitro Diagnostics therapeutic area. Robust methodologies ensure an accurate overview of the market to deliver a comprehensive and precise market analysis. It incorporates primary sources from both the demand and supply sides. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Product Insights
Ireland PCR Systems Market Share
PCR Systems (In Vitro Diagnostics) Ireland Market Share report provides quantitative market trends within the In Vitro Diagnostics therapeutic area. Robust methodologies ensure an accurate overview of the market to deliver a comprehensive and precise market analysis. It incorporates primary sources from both the demand and supply sides. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Product Insights
Israel PCR Systems Market Share
PCR Systems (In Vitro Diagnostics) Israel Market Share report provides quantitative market trends within the In Vitro Diagnostics therapeutic area. Robust methodologies ensure an accurate overview of the market to deliver a comprehensive and precise market analysis. It incorporates primary sources from both the demand and supply sides. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Product Insights
United Kingdom PCR Systems Market Share
PCR Systems (In Vitro Diagnostics) United Kingdom Market Share report provides quantitative market trends within the In Vitro Diagnostics therapeutic area. Robust methodologies ensure an accurate overview of the market to deliver a comprehensive and precise market analysis. It incorporates primary sources from both the demand and supply sides. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day of the purchase, excluding weekends and holidays. Certain sections of the...
-
Sector Analysis
COVID-19 Tests Market Size by Segments, Share, Regulatory and Reimbursement, Procedures and Forecast to 2033
COVID-19 Tests Market Report Overview The COVID-19 Tests market size was valued at $75.4 billion in 2022. COVID-19 testing is done through three primary NAATs: Singleplex NAATs, POC NAATs, and Multiplex NAATs. COVID-19 NAATs are the major device used due to its historically established and widespread use and associated equipment. COVID-19 Tests Market Outlook 2022-2023 ($ Billion) The COVID-19 Tests market research report is built to visualize quantitative market trends within in-vitro diagnostics therapeutic areas. Furthermore, the model discusses in...
-
Sector Analysis
Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory and Reimbursement, Procedures and Forecast to 2033
Neisseria Gonorrhoeae Tests Market Report Overview The Neisseria Gonorrhoeae Tests market size was valued at $383.7 million in 2022. Neisseria Gonorrhoea is one of the most common sexually transmitted diseases (STD) worldwide, caused by the bacteria Neisseria gonorrhoea. N. gonorrhoea infections are more common in young adults. Other groups at higher risk of contracting gonorrhoea include individuals with multiple sexual partners, individuals with another STD, men having sex with men (MSM), and sex workers. Increases in the incidence of Neisseria...
-
Sector Analysis
BCR-ABL Tests Market Size by Segments, Share, Regulatory and Reimbursement, Procedures and Forecast to 2033
BCR-ABL Tests Market Report Overview The BCR-ABL Tests market size was $25.7 million in 2022. Breakpoint Cluster Region - Tyrosine-Protein Kinase ABL1 fusion gene (BCR-ABL) tests are carried out to detect fusion gene mutations in patient tissue samples. The outcome may guide therapies to treat various cancers including chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and acute myelogenous leukemia (AML). BCR-ABL Tests Market Outlook, 2022-2033 ($ Million) Â For more insights into the BCR-ABL Tests market forecast, download a free...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.